A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?

(MedPage Today) -- A much-awaited treatment for postpartum depression, zuranolone (Zurzuvae), hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news